does semaglutide pass through breast milk semaglutide is expected to get into breastmilk in small amounts - GLP-1 breastfeeding reddit semaglutide is not transmitted into breastmilk Does Semaglutide Pass Through Breast Milk? Understanding the Latest Research

GLP-1 breastfeeding study For mothers managing conditions like type 2 diabetes or obesity, the question of does semaglutide pass through breast milk is a critical one. As semaglutide and other GLP-1s become more widely prescribed for weight loss and diabetes management, understanding their safety profile during lactation is paramount. Emerging research offers reassuring insights, suggesting that the risks associated with semaglutide exposure through breast milk may be minimal, though caution and professional guidance remain essential.Can You Take Semaglutide While Breastfeeding?

Numerous studies have investigated the transfer of semaglutide into human breast milk. A significant finding from researchers at Texas Tech University Health Sciences Center, as shared by Krutsch, indicated that the drug was undetectable in breast milk samples. This suggests minimal exposure for breastfed infantsCan you take semaglutide while breastfeeding?. Similarly, a study published in the journal *Nutrients* in 2024 reported that semaglutide was not found in tested breast milk. These findings align with the observations in the LactMed® database, which noted that in a study involving eight breastfeeding mothers taking the drug subcutaneously, semaglutide was not detectable in the milk.2023年10月1日—Based on an animal study,semaglutide is expected to get into breastmilk in small amounts. Your healthcare providers can talk with you about ... Crucially, their breastfed infants experienced no adverse effects2024年10月25日—Whilesemaglutides appear low-risk during breastfeeding due to limited transfer into breast milk, professional guidance is crucial for both diabetes management..

The pharmacological properties of semaglutide also contribute to the understanding of its potential transfer. As a large peptide molecule, semaglutide has a high molecular weight and a strong affinity for plasma proteins. This makes it very unlikely to pass into mothers' milk in clinically significant quantities. Injectable forms, like those used for Ozempic and Wegovy, are unlikely that injectable semaglutide and injectable liraglutide would transfer freely into breastmilk due to these factors. Furthermore, even if absorbed orally, semaglutide demonstrates poor oral absorption, further reducing the potential for systemic exposure to the infant.2025年3月31日—Recent studies—including one published in 2024 show thatonly minuscule amounts of semaglutide enter breast milk. So far, no harmful effects ... One study calculated a worst-case scenario for the relative infant dose (RID) and found that semaglutide was not detected in any of the collected human milk samplesSemaglutide & Breastfeeding - InfantRisk Forums.

While the current evidence is largely encouraging, with many studies pointing to minimal risk to breastfed babies, it is important to acknowledge that research is ongoing. Some animal studies, specifically in lactating rats, have indicated that semaglutide does pass into breast milk. However, the relevance of these findings to human physiology is not definitively established, and the transfer in humans appears to be exceptionally low. Some reports suggest that semaglutide in breast milk is likely to be very low, and that semaglutide is not transmitted into breastmilk, at least to the lower limit of detection.

Despite these positive findings, the advice from many healthcare providers and manufacturers, particularly for oral semaglutide (Rybelsus®), is to not take semaglutide while breastfeeding. This general recommendation stems from the fact that it is still unclear if it can pass into breast milk or affect breastfed babies in ways not yet identified.Krutsch shared findings from her research showing that the drug wasundetectable in breast milk samples, suggesting minimal exposure to infants. Therefore, for breastfeeding mothers who are considering or currently using semaglutide (such as Ozempic or Wegovy), a thorough discussion with their healthcare provider is crucial. They can weigh the benefits of managing conditions like diabetes and obesity against the potential, albeit seemingly low, risks.

Experts suggest that semaglutides appear low-risk during breastfeeding due to limited transfer into breast milk, but professional guidance is critical.2024年8月15日—Semaglutide was not detected in any of the collected human milk samples. A worst-case scenario of the relative infant dose (RID) was calculated ... While recent studies consistently show no detectable levels of semaglutide in breast milk or only minuscule amounts of semaglutide enter breast milk, some sources recommend that semaglutide should be used cautiously during breastfeeding, specifically in newborns. The consensus leans towards semaglutide (Wegovy) may not transfer into breast milk or harm infants, but the research remains limited. Ultimately, the decision to use semaglutide while breastfeeding should be a personalized one, made in collaboration with a healthcare professional who can provide the most up-to-date information and consider individual circumstances. The key takeaway is that while the evidence is increasingly positive regarding the low transfer of semaglutide into milk, direct consultation with a doctor remains the recommended course of action.